Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Polona Novak
Observed names:
Novak, Polona,
P. Novak
Institutions:
University of Ljubljana,
Ljubljana University Medical Centre
Observed institutions:
University of Ljubljana,
Ljubljana University Medical Centre,
University Medical Center Hamburg-Eppendorf
ORCID:
0009-0003-9392-8894
Observed ORCID:
0009-0003-9392-8894
OpenAlex ID:
A5015591413
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis
2024
·
Nico Gagelmann
, Gabriela S. Hobbs
, et al.
·
American Journal of Hematology
·
38
PDF
Allogeneic Stem Cell Transplantation for Patients with Lower-Risk Myelodysplastic Syndrome
2020
·
Polona Novak
, Tatjana Zabelina
, et al.
·
Transplantation and Cellular Therapy
·
8
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
·
Blood Cancer Discovery
·
2
CAR T therapy in adult DLBCL patients in Slovenia: Evaluation of predictive scores for outcomes and adverse events
2026
·
Lucija Sršen
, Irena Auersperger
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
PDF
Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression
2020
·
Polona Novak
, Evgeny Klyuchnikov
, et al.
·
Bone Marrow Transplantation
·
1
Supplementary Table S3 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Data from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Figure S1 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Figure S2 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Table S1 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Figure S4 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Table S2 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Methods 1 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
Supplementary Figure S3 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma
2026
·
Maximilian Merz
, Tomas Jelinek
, et al.
CAR T therapy in adult DLBCL patients in Slovenia: Evaluation of predictive scores for outcomes and adverse events
2026
·
Sršen, Lucija
, Auersperger, Irena
, et al.
·
Figshare
CAR T-cells or bispecific antibodies for relapsed/refractory multiple myeloma: Head-to-head real-world european comparison
2025
·
Maximilian Merz
, Tomas Jelinek
, et al.
·
Blood
PDF
Role of Splenic Irradiation Prior to Transplant for Myelofibrosis: A Global Collaboration
2023
·
Nico Gagelmann
, Gabriela S. Hobbs
, et al.
·
Blood
PDF
Pb1724 Flt3 Mutated Aml: the Role of Cladribine and Midostaurin Added to the Standard Intensive Chemotherapy ‐ Single Centre Experience From Umc Ljubljana, Slovenia
2019
·
S. Anzej Doma
, M. Škerget
, et al.
·
HemaSphere
Show more works
View as search
Works count:
18
Citation count:
51
H-index:
2
I10-index:
1
Year
Topic
Type